User:Mary Mendoza/Notebook/CHEM572 Exp. Biological Chemistry II/2013/03/20: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
(2 intermediate revisions by the same user not shown)
Line 13: Line 13:
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
* Kaempferol trials were started.
* Kaempferol trials were started.
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM.
* After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. In addition, cuvettes will also contain 300 μL of DMSO.
* For the following week, a new aspiring stock solution will be prepared.


==adenosine vs. aspirin==
==adenosine vs. aspirin==
* The histogram below displays the non-inhibitory effect of aspirin.


[[Image:Bar.png|center]]
[[Image:Bar2.png]]


==Tables==
==Tables==

Revision as of 17:56, 22 March 2013

Project name <html><img src="/images/9/94/Report.png" border="0" /></html> Main project page
<html><img src="/images/c/c3/Resultset_previous.png" border="0" /></html>Previous entry<html>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</html>Next entry<html><img src="/images/5/5c/Resultset_next.png" border="0" /></html>

Histogram

  • It was decided to create a histogram for each inhibitor which includes the flavonoids and the non-nucleoside, acetylsalicylic acid analogs. Each inhibitor consisted of three trials.
  • From Sigma, 500 μM Kaempferol (C15H10O6, MW 286.24 g/mol) stock solution was prepared in dimethylsulfoxide (DMSO).
  • A kinetic assay run of 40 μM adenosine without inhibitors was executed through the kinetics of the UVProbe system.
  • After the three trials of 40 μM adenosine, aspirin trials were conducted.
  • The aspirin trials did not show inhibition. A possible conclusion for the inconsistency was that the aspirin stock solution has deteriorated.
  • Kaempferol trials were started.
  • After examining some of the data, it was concluded to adjust the 40 μM adenosine concentration to 25 μM. In addition, cuvettes will also contain 300 μL of DMSO.
  • For the following week, a new aspiring stock solution will be prepared.

adenosine vs. aspirin

  • The histogram below displays the non-inhibitory effect of aspirin.

Tables

  • The data below was taken from Dhea Patel.
  • To measure the mass of Kaempferol and the volume of DMSO:

  • Table of volumes and concentrations:

px550



Retrieved from "https://openwetware.org/mediawiki/index.php?title=User:Mary_Mendoza/Notebook/CHEM572_Exp._Biological_Chemistry_II/2013/03/20&oldid=685031"